Lightning Talk and Exhibitor Opportunity, Organized by MIT Media Lab with contributions from MIT Startup Exchange and Takeda Pharmaceuticals
P&G is looking for a number of solutions to improve human-robot collaboration and safety. There are three distinct use cases: highly reliable object detection, deterministic localization for mobile robots, and highly reliable recognition of humans.
In the coming months, the MIT Industrial Liaison Program (ILP) is pleased to present a special webinar series for China and Southeast Asia featuring leading researchers, field experts, and startups to share insights in energy, nanomaterials, novel photonics, robotics, city planning, healthcare, and more.
Gerdau logistics team is looking for solutions that can help them with outbound logistics, demand planning and supply chain.
Safran Explore is looking for the technologies that will shape the future of aerospace, defense, and space. Five challenges are currently open until September 30. Select startups will access technical, business & industrial support, access test facilities, R&D teams, fast-track industrialization and more.
The Taiwan Chip-based Industrial Innovation Program (Taiwan CbI) is a collaborative effort by various Taiwanese government ministries, leveraging Taiwan’s semiconductor expertise by integrating chips with key innovations. Startups should be focused on IC design innovations and Chip-based innovative applications in the following industries: data & security, mobility, sustainability, manufacturing and medtech.
Meter: Next-generation volumetric imaging for manufacturing inspection Realtime Robotics: Autonomous Motion Planning and Spatial Perception for Industrial Automation Akasha Imaging: "See it, Build it!" Perception Solutions for Manufacturing Eureka Robotics: Enabling High Accuracy – High Agility automation
We seek three startups to present in front of approximately 200 individuals from industry, academia, and government, plus a stand-up booth during all networking breaks and a buffet luncheon. Startups will be considered from any segment of healthcare, including novel medical devices, digital health, pharma/nutrition, etc.